After Google Inc (GOOGL), Apple Inc. (AAPL) Is The Next To Collect DNA Samples To Further Genetic Disease Studies
Apple Inc. (NASDAQ:AAPL) is joining the growing list of companies and organizations interested in studying DNA. From Google Inc (NASDAQ:GOOGL) to the U.S. government, efforts are being made to gain more knowledge about diseases and genetics is part of the focus. Efforts are geared towards learning more about diseases with the hope of combating debilitating disorders like Parkinson’s disease.
Apple Inc. (NASDAQ:AAPL), in its efforts to facilitate better research on DNA, is about to begin its genetic databasing. What Apple wants to do is collect DNA from its various users through what has been described as a secure portal. The idea behind gathering DNA samples is part of Apple’s program that launched in March, known as the ResearchKit program. Those who volunteer their health information for the ResearchKit program will also benefit from being selected to participate in certain clinical studies.
Apple already has plans for at least two studies with organizations that include Mount Sinai Hospital in New York and the University of California in San Francisco.
For DNA collection efforts, Apple Inc. (NASDAQ:AAPL) will provide users with kits on which they can apply saliva and return to laboratories approved by the company. The data will be stored in a cloud computing platform with some findings being made available on the user’s iPhone device.
Driving realization of a connected world
Apple Inc. (NASDAQ:AAPL) isn’t disclosing much about its genetic databasing plans. However, what is happening all around is that technology companies are bringing their various capabilities to accelerate the envisioned connected world. Under the so-called Internet of Things, or Internet of Everything in some quarters, about 50 billion devices are expected to be connected to the Internet by 2020. Such devices include anything from vehicles to goats in the field.
Apple Inc. (NASDAQ:AAPL) and Google are locked up in a race to build a genetic library to foster medical research. There is no doubt other prominent names in the technology world, like Microsoft Corporation (NASDAQ:MSFT) and Facebook Inc (NASDAQ:FB), might also show interest in health databasing.
Latest posts by Neha Gupta (see all)
- Is Facebook Inc (NASDAQ:FB) Winning Or Losing In Virtual Reality Space? - May 27, 2016 07:35 AM PST
- No Growth In Costco Wholesale Corporation (NASDAQ:COST)’s 3Q Comps Explained - May 27, 2016 07:34 AM PST
- How Will International Business Machines Corp. (NYSE:IBM)’s Big Data University Help? - May 27, 2016 07:33 AM PST